The identification of U-251 and UW479, due to their unique telomere phenotype after ATRX loss, provides a key step in the elucidation of the molecular mechanism(s) of ALT and the identification of promising therapeutic targets for ALT-positive cancers [29, 58]. The gene discussed is ATRX; the disease is cancer.